That reflects what Health and Human Services Secretary Xavier Becerra says was an overestimate in costs of covering a controversial new Alzheimer’s drug.
WASHINGTON — Medicare recipients will get a premium reduction — but not until next year — reflecting what Health and Human Services Secretary Xavier Becerra said Friday was an overestimate in costs of covering an expensive and controversial new Alzheimer’s drug.
Medicare Part B premiums jumped by $22 a month, to $170.10, for 2022, in part because of the cost of the drug Aduhelm, which was approved despite weak evidence that it could slow the progression of Alzheimer’s.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
New 2023 Audi A4 Avant undergoes tests in the Alps | AutocarNext-generation A4 range will be topped by electric and hybrid RS4 duo
Les mer »
Preen by Thornton Bregazzi Resort 2023 CollectionPreen by Thornton Bregazzi Resort 2023 collection, runway looks, beauty, models, and reviews.
Les mer »
Review: 2023 Acura Integra recaptures glory of days pastFrom Civic Si beginnings, Acura spins a winning reincarnation of its original compact-car classic.
Les mer »
Congressional Budget Office says inflation to last into 2023The Congressional Budget Office released an economic outlook Wednesday saying high inflation will persist into next year, likely causing the federal government to pay higher interest rates on its debt.
Les mer »
Peter Kay's 2023 tour announcement will be culmination of star's gradual returnPeter Kay's 2023 tour announcement will prove to be a culmination of his gradual return to the spotlight after cancelling all his commitments in 2017 due to personal reasons
Les mer »